Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach

GlobeNewswireMar 13 08:30 ET

Femasys Achieves CE Mark for FemBloc, Paving the Way for European Market Entry and Justifying Buy Rating

TipRanks12:05 ET · Ratings

H.C. Wainwright Maintains Femasys(FEMY.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsFeb 25 12:31 ET · Ratings

Femasys's FemBloc: A Promising Investment in Permanent Contraceptive Innovation

TipRanksFeb 25 12:15 ET

Femasys Announces Publication of 'Positive' Results From FemBloc Trials

TipRanksFeb 25 09:25 ET

Express News | Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results From Fembloc® Permanent Birth Control Clinical Trials

ReutersFeb 25 09:20 ET